|
CVS Caremark Faces Lawsuit Over Dropping Zepbound
|
Written by: J. Smith |
Hits: 105
|
|
Eli Lilly Narrows Focus for Oral GLP-1 Naperiglipron
|
Written by: J. Smith |
Hits: 137
|
|
Wegovy Outperforms Mounjaro in Cardiovascular Outcomes
|
Written by: J. Smith |
Hits: 156
|
|
Teva Launches First Generic GLP-1 for Obesity
|
Written by: J. Smith |
Hits: 96
|
|
Novo Nordisk Strikes $550M RNA Deal with Replicate Bioscience
|
Written by: J. Smith |
Hits: 109
|
|
FDA Expands Repatha Access to More High-Risk Adults
|
Written by: J. Smith |
Hits: 149
|
|
Lilly Advances Orforglipron Toward Approval After Third Phase 3 Win
|
Written by: J. Smith |
Hits: 156
|
|
Signos Press Release Raises Questions About FDA Clearance Claims
|
Written by: J. Smith |
Hits: 210
|
|
Novo Nordisk Expands $499 Cash-Pay Option to Ozempic
|
Written by: J. Smith |
Hits: 158
|
|
FDA Approves Wegovy for MASH Treatment
|
Written by: J. Smith |
Hits: 177
|
